Drugs in development · updated 11 November 2026
Ulcer: drugs in development
What it is
An ulcer is a discontinuity or break in a bodily membrane that impedes normal function of the affected organ. According to Robbins's pathology, "ulcer is the breach of the continuity of skin, epithelium or mucous membrane caused by sloughing out of inflamed necrotic tissue." Common forms of ulcers recognized in medicine include: Ulcer (dermatology), a discontinuity of the skin or a break in the skin.
Description not checked by Phuturdex: excerpt from the introduction of the article “Ulcer” on English Wikipedia, en.wikipedia.org · version of 2 June 2025 · licence CC BY-SA 4.0.
As of 11 November 2026 there are 8 active clinical trials (recruiting or ongoing, phases I–III) on 8 drugs for ulcer. 8 are experimental, that is not yet approved in the United States.
In Phuturdex every drug has its map of sites in Europe, every trial and its alerts, and you get an email when something changes. Full access free until 31 March 2027, no card needed.
Experimental drugs
Not yet approved by the US FDA for any indication.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| PropranololHemangiol® | II–III | 1 | NCT06798363 |
| VonoprazanVonoparazan | III | 1 | NCT07608536 |
| ATH-063 | II | 1 | NCT07513181 |
| EtrasimodVelsipity® | II | 1 | NCT07470879 |
| N-AcetylcysteineAcetylcysteine, N-acetyl-L-cysteine | II | 1 | NCT06354712 |
| PL8177 | II | 1 | NCT05466890 |
| Taurine | II | 1 | NCT07567742 |
| Telacebec | II | 1 | NCT06481163 |
Sorted by most advanced phase and number of active trials.
Sites in Europe
18 sites of the active trials in 5 European countries, 18 recruiting.
- United Kingdom5
- Germany4
- Poland4
- Italy3
- France2
Sites declared by the sponsors on ClinicalTrials.gov; region worked out by Phuturdex from the geographic point. The list of sites with city and recruitment status is in the app. See the sites →
All 8 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Broader categories
- Digestive System Diseases 1,558 drugs
- Gastrointestinal disease 1,031 drugs
- Colonic disease 677 drugs
- Intestinal disease 785 drugs
- Gastroenteritis 192 drugs
- Neoplasm 3,413 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 11 November 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D014456 “Ulcer”.